1.A clinical effect of retreatment by prothionamide, cycloserine, para-aminosalicylic acid, streptomycin(kanamycin or tuberactinomyc-in) on pulmonary tuberculosis.
Cheol Shick SHIN ; Young Jae IM ; Young Jun KIM ; Seok Shin KOH ; Moon Shik KIM
Tuberculosis and Respiratory Diseases 1992;39(2):167-171
No abstract available.
Aminosalicylic Acid*
;
Cycloserine*
;
Prothionamide*
;
Retreatment*
;
Tuberculosis, Pulmonary*
2.The clinical aspects of pulmonary tuberculosis patient failed in retreatment.
Young Jae IM ; Ju Young SONG ; Jae Man JEONG ; Young Jun KIM ; Moon Shik KIM
Tuberculosis and Respiratory Diseases 1993;40(4):404-410
No abstract available.
Humans
;
Retreatment*
;
Tuberculosis, Pulmonary*
3.A Case of Mucoepidermoid Carcinoma in Pulmonary Tuberculosis Patient.
Jae Man JEONG ; Ju Young SONG ; Jae Rack HONG ; Young Jun KIM ; Moon Shik KIM
Tuberculosis and Respiratory Diseases 1994;41(4):429-434
Mucoepidermoid carcinoma of lung are rare carcinoma arising from the submucosal glands tissue of the proximal tracheobronchial tree. The carcinoma can be divided into low grade and high grade varienties. The most important factors in the prognosis include histological grading and the ability to achieve a complete surgical resection. We experienced a case of high grade mucoepidermoid carcinoma in pulmonary tuberculosis patient of 67 years old male who has been suffered from left chest pain for several weeks. He was not treated and died seventeen months later.
Carcinoma, Mucoepidermoid*
;
Chest Pain
;
Humans
;
Lung
;
Male
;
Prognosis
;
Trees
;
Tuberculosis, Pulmonary*
4.Effectiveness of boric acid as a stomach poison for the German cockroach (Blattella germanica L.) Control.
Moon Shik ZONG ; Song Jun KIM ; Sung Hoi KOO ; Ryang Il HAN
The Korean Journal of Parasitology 1972;10(2):95-99
The author carried out a study on the effectiveness of the boric acid as a stomach poison for German cockroach control from July to September 1971. The test was performed by the feeding method under conditions of 20 C and 80 per cent relative humidity. The baits were composed of one control group and five different combination groups with boric acid and sugar as follows. 10 g sugar only(control group), 1 g powedered boric acid to 9 g sugar(1:9 poison baits), 2 g powdered boric acid to 8 g sugar(2:8 poison baits), 4 g powdered boric acid to 6 g sugar(4:6 poison baits), 5 g powdered boric acid to 5g sugar(5:5 poison baits), 10 g powdered boric acid only (10:0 poison baits). The insects were composed of 360 female adult German cockroaches collected by traps at the kitchens of restaurants and house holds in Seoul City. The results were as follows: The total mortality by poison baits in 72 hours after treatment were: 44.3 per cent by 1:9 poison baits , 79.4 per cent by 2: poison baits , 96.7 per cent by 4:6 poison baits(the most effective poison baits), 88.3 per cent by 5:5 poison baits, 91.1 per cent by 10:0 poison baits. The peak mortality by the treatment hours were: Up to 21 hours: 23.3 per cent by 5:5 poison baits, 20.0 per cent by 10:10 poison baits, From 24 to 48 hours: 71.1 per cent by 4:6 poison baits, 55.6 per cent by 10:0 poison baits, From 48 to 72 hours: 21.9 per cent by 2:8 poison baits, 19.6 per cent by 1:9 poison baits. The most effective treatment hours was from 24 to 48 hours.
parasitology-arthropoda-cockcroach
;
Blattella germanica
;
chemotherapy
;
boric acid
5.Left to right ratio of autopneumonectomy state in pulmonary tubercu-losis patients.
Cheol Shick SHIN ; Jae Man JEONG ; Young Jae IM ; Young Jun KIM ; Seok Shin KOH ; Moon Shik KIM
Tuberculosis and Respiratory Diseases 1992;39(4):343-347
No abstract available.
Humans
7.Rapid detection of human cytomegalovirus(HCMV) in urine from kidney transplant patients by polymerase chain reaction(PCR) and hybridization.
Tai Gyu KIM ; Moon Won KANG ; Wan Shik SHIN ; Mun Gan RHYU ; Yeun Jun JUNG ; Hoon HAN ; Gum Ryong KIM
Journal of the Korean Society for Microbiology 1992;27(1):79-86
8.Rapid detection of human cytomegalovirus(HCMV) in urine from kidney transplant patients by polymerase chain reaction(PCR) and hybridization.
Tai Gyu KIM ; Moon Won KANG ; Wan Shik SHIN ; Mun Gan RHYU ; Yeun Jun JUNG ; Hoon HAN ; Gum Ryong KIM
Journal of the Korean Society for Microbiology 1992;27(1):79-86
9.A Case of SVC Obstruction in Behcet's Syndrome.
Chan Hee LEE ; Hong Woo LEE ; Jun Keun JUNG ; Hyeun Young PARK ; Jun Han SHIN ; Jun KWAN ; Hwark Moon KWAN ; Hyeun Soung KIM ; Choon Shik YOUN
Korean Circulation Journal 1993;23(6):946-952
The clinical triad of relapsing iritis, ulcers of the mouth and genitalia was first described in 1939 by Hulusi Behcet. This entity, originally confined to the above triad of symptoms appears to be systemic disease manifested by skin lesion, thrombophlebitis, neurologic, cardiovascular or visceral symptoms. The vascular involvement in Behcet's syndrome has been reported since Mischima first described a case in 1961, four types of vascular lesion are freuqnetly observed most commonly on the inferior or superior vena cava. Treatments consist of anticoagulation and administering oral steroids. We report a case of SVC obstruction in 36 years old female patient with Behcet's syndrome.
Adult
;
Behcet Syndrome*
;
Female
;
Genitalia
;
Humans
;
Iritis
;
Mouth
;
Skin
;
Steroids
;
Thrombophlebitis
;
Ulcer
;
Vena Cava, Superior
10.A Clinical Effect of Ofloxacin, Prothionamide, Cycloserine Streptomycin (Kanamycin or Tuberactinomycin) in Retreatment of Pulmonary Tuberculosis.
Ju Young SONG ; Min Kyu YOO ; Jae Rack HONG ; Jae MAN JEONG ; Young Jun KIM ; Moon Shik KIM
Tuberculosis and Respiratory Diseases 1995;42(3):295-301
BACKGROUND: The serious problems in retreatment of pulmonary tuberculosis are a significant proportion of drug resistance. Preferably retreatment should contain the drugs which has never used before, so drug retreatment is limited in selection. A new antibacterial substance, ofloxacin(OFX) is the activity against mycobacterium tuberculosis and it has been used in the treatment of pulmonary tuberculosis. The present report concerns the result of retreatment of pulmonary tuberculosis patients containing OFX treated at National Kongju Tuberculosis Hospital. METHOD: A retrospective study was made through the regular follow up of 92 smear positive cases, who were treated by four drugs regimen between Mar 1991 and June 1994 at National Kongju Tuberculosis Hospital. Four drugs were, namely prothionamide, cycloserine, ofloxacin and streptomycin(kanamycin or tuberactinomycin). The duration of follow up was over one year. RESULTS: 1) Out of 92 cases with positive sputum AFB smear, 67(73%) achieved the negative conversion. 2) Considering the negative sputum conversion in all the groups, the vast majority(85%) of sputum conversion occurred within the first 4 months. 3) The roentgenological improvement occurred in 49 percent on the whole and when the extent of disease was minimal, moderately, far advanced pulmonary tuberculosis, sputum AFB smear negative response to retreatment was 100%, 93%, 68%, respectively. 4) When the duration of patient's illness was less than 1 year, 1 to 3 years, 3 to 5 years and more than 5 years, sputum AFB smear negative response to retreatment was 87%, 76%, 65% and 55%, respectively. 5) Adverse reaction to prothionamide, with complaints of gastrointestinal troubles was common and hepatic dysfunction without jaundice was observed in 7 percent, convulsion in 1 percent, that to cycloserine occurred renal dysfunction & psycosis & convulsion, 2%, 1%, 1%, respectively. Tinnitus with KM occurred in 1% and dirrhea with OFX in 4%. CONCLUSION: The duration of patient's illness was shorter, sputum AFB smear negative response rate was better. Radiologic responses were not remarkable, but extent of disease by national tuberculosis association was smaller, the result of retreatment was better. Adverse reaction of the secondary antituberculosis agent was mainly observed gastrointestinal troubles, as regard to tolerance to the secondary drugs the role of the physician is of very important value and toxic effects can be overcome by the strong confidence.
Chungcheongnam-do
;
Cycloserine*
;
Drug Resistance
;
Follow-Up Studies
;
Hospitals, Chronic Disease
;
Humans
;
Jaundice
;
Mycobacterium tuberculosis
;
Ofloxacin*
;
Prothionamide*
;
Retreatment*
;
Retrospective Studies
;
Seizures
;
Sputum
;
Streptomycin*
;
Tinnitus
;
Tuberculosis
;
Tuberculosis, Pulmonary*